Now Carreyrou is out with a book-length exposé, “Bad Blood,” which uses interviews with more than 150 people to show how Holmes briefly became the world’s youngest self-made billionaire. Remarkably, that omission didn’t stand in the way of Theranos’ financial success until late 2015, when Pulitzer Prize-winning reporter John Carreyrou began to expose the company’s lies in a series of investigative stories in the Wall Street Journal. The problem was, Theranos had no such device.
The device would eliminate thousands of deaths from adverse drug reactions, identifying diseases early, and run any blood test for less than half the normal cost, potential customers were told. Theranos’ blood-testing device was “the most important thing humanity has ever built,” Holmes once told a crowd of employees. Founder Elizabeth Holmes, a college dropout, exuded Steve Jobs-like confidence as she spun a founding narrative so powerful that it could induce a kind of blindness in business executives who should have known better. The company was selling a revolutionary blood-analysis machine that boasted a sophisticated touch screen and a sleek designer case. Englisch.Theranos, the Silicon Valley health care startup, seemed to have everything it would need to live up to its hype and become the next breakout tech phenom. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings from journalists to their own employees.
Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. There was just one problem: The technology didn t work. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes s worth at an estimated $4.5 billion. The New YorkTimes Book ReviewIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: abrilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. With a new Afterword coveringher trial and sentencing, bringing the story to a close. Neuware -NATIONAL BESTSELLER The gripping story ofElizabeth Holmes and Theranos one of the biggest corporate frauds in history a tale of ambition and hubris set amid the bold promises of Silicon Valley, rigorously reported bythe prize-winning journalist.
0 kommentar(er)
